Agilent Technologies

A

Market cap $43.4B

A group of dividend raisers OBT, UBSI, DDS, PATK and A stand out as investors seek stability amid volatile markets, rate-cut hopes and mixed economic signals.

Agilent Technologies delivered strong Q4 2025 results, with revenue and EPS beating expectations and robust growth in Life Sciences and Diagnostics segment. Management forecasts FY26 revenue growth of 6% and normalized EPS between $5.86 and $6.00, signaling continued solid performance. Agilent now trades at a 6% premium to fair value after a 23% rally, outpacing the S&P 500 handily since my August coverage.

A report higher Q4 revenues and lifts its 2026 outlook, yet the stock slips as margins narrow across key business segments.

The Investment Committee debates their top small- and mid-cap names for 2026.

Agilent Technologies Inc (NYSE: A) reported upbeat earnings for the fourth quarter on Monday.

Agilent Technologies, Inc. ( A ) Q4 2025 Earnings Call November 24, 2025 4:30 PM EST Company Participants Tejas Savant Padraig McDonnell - CEO, President & Director Adam Elinoff - Senior VP, CFO & Principal Financial Officer Rodney Gonsalves - Principal Accounting Officer, VP & Corporate Controller Simon May - SVP & President of LDG Angelica Riemann - Senior VP & President of Agilent CrossLab Group Mike Zhang - Senior VP & President of Applied Markets Group Conference Call Participants Tycho Peterson - Jefferies LLC, Research Division Patrick Donnelly - Citigroup Inc., Research Division Daniel Leonard - UBS Investment Bank, Research Division Douglas Schenkel - Wolfe Research, LLC Brandon Couillard - Wells Fargo Securities, LLC, Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Jack Meehan - Nephron Research LLC Daniel Brennan - TD Cowen, Research Division Michael Ryskin - BofA Securities, Research Division Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Casey Woodring - JPMorgan Chase & Co, Research Division Catherine Ramsey - Robert W. Baird & Co. Incorporated, Research Division Luke Sergott - Barclays Bank PLC, Research Division Presentation Operator Good afternoon.

Agilent Technologies, Inc. ( A ) Bank of America Global Healthcare Conference 2025 September 25, 2025 4:50 AM EDT Company Participants Padraig McDonnell - CEO, President & Director Conference Call Participants Michael Ryskin - BofA Securities, Research Division Presentation Michael Ryskin BofA Securities, Research Division I'm Mike Ryskin. I'm on the Bank of America Life Science Tools and Diagnostics team based in New York.

While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended October 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Agilent Technologies (A) came out with quarterly earnings of $1.59 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.46 per share a year ago.

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies, Inc. (NYSE: A) today reported revenue of $1.86 billion for the fourth quarter ended October 31, 2025, exceeding revenue guidance and representing growth of 9.4% reported and up 7.2% core(1) compared with the fourth quarter of 2024. Fourth-quarter GAAP net income was $434 million, or $1.53 per share. This compares with $351 million, or $1.22 per share, in the fourth quarter of 2024. Non-GAAP(2) net income was $452 million, or $1.59 per.